Your browser doesn't support javascript.
loading
Harnessing SARS-CoV-2-specific CD8+ T cells to kill target tumor cells for cancer immunotherapy.
Jung, Keunok; Ko, Deok-Han; Jang, Jeong-Yun; Kim, Young Rong; Heo, Jung Yeon; Kim, Yong-Sung.
Afiliación
  • Jung K; Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Ko DH; Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea.
  • Jang JY; Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea.
  • Kim YR; Department of Infectious Diseases, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Heo JY; Department of Infectious Diseases, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Kim YS; Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Republic of Korea.
Cancer Commun (Lond) ; 44(1): 173-177, 2024 01.
Article en En | MEDLINE | ID: mdl-37856250
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Límite: Humans Idioma: En Revista: Cancer Commun (Lond) Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Límite: Humans Idioma: En Revista: Cancer Commun (Lond) Año: 2024 Tipo del documento: Article